All In Biotech

Drug Trial Radar · NCT00383799

Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia

Comparison of Intravenous Amiodarone Versus Intravenous Procainamide for the Acute Treatment of Regular and Haemodynamically Well Tolerated Wide QRS Tachycardia (Probably of Ventricular Origen). The PROCAMIO Multicenter Study

Last checked: Nov 19, 2026Latest source record: Apr 6, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 302 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

302

Actual

Start

Sep 2005

Primary completion

Jun 2011

Study completion Jun 2011

Sponsor

Lead sponsor
Hospital General Universitario Gregorio MarañonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 4, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether intravenous amiodarone has less cardiac significant adverse events compared to intravenous procainamide in the acute treatment of haemodynamically well tolerated wide QRS tachycardia, the majority of them of probably ventricular origen.

Conditions

  • Ventricular Tachycardia
  • Wide QRS Tachycardia

Interventions

  • iv AmiodaroneDrug

  • iv ProcainamideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To compare clinically significant cardiac adverse events occurring within 40 minutes from treatment initiationTime frame: 40 minutes

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital General

    Alicante, Spain

  • Hospital Clinic

    Barcelona, Spain

  • Hospital Vall d'Hebron

    Barcelona, Spain

  • Hospital de Basurto

    Bilbao, Spain

  • Hospital San Cecilio

    Granada, Spain

  • Hospital Virgen de las Nieves

    Granada, Spain

  • Hospital General Universitario Gregorio Marañón

    Madrid, Spain

  • Hospital 12 de Octubre

    Madrid, Spain

  • Hospital Clínico San Carlos

    Madrid, Spain

  • Hospital de La Princesa

    Madrid, Spain

  • Hospital de Móstoles

    Madrid, Spain

  • Hospital General Universitario La Paz

    Madrid, Spain

  • Hospital Puerta de Hierro

    Madrid, Spain

  • Hospital Carlos Haya

    Málaga, Spain

  • Hospital Clínico Virgen de la Victoria

    Málaga, Spain

  • Hospital Virgen de la Arrixaca

    Murcia, Spain

  • Hospital de Son Dureta

    Palma de Mallorca, Spain

  • Hospital de Son Llatzer

    Palma de Mallorca, Spain

  • Hospital de Donostia

    San Sebastián, Spain

  • Hospital de Valme

    Seville, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, Spain

  • Hospital Virgen de la Salud

    Toledo, Spain

  • Hopital Clínico Universitario

    Valencia, Spain

  • Hospital Río Hortega

    Valladolid, Spain

  • Hospital El Escorial

    El Escorial, Madrid, Spain

  • Hospital Universitario de Getafe

    Getafe, Madrid, Spain

  • Hospital Santa María del Rosell

    Cartagena, Murcia, Spain

  • Fundación Hospitalaria de Cieza

    Cieza, Murcia, Spain

  • Hospital Los Arcos

    San Javier, Murcia, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.